Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EnBio HoldingsTSE:6092 +1.11%58 PEG Ratio is 12.55 as of Jul. 17, 2026, which is 2064% above its 10-year median of 0.58. GuruFocus rates TSE:6092 with a GF Score™ of 58/100 and a GF Value™ of 円799.37 (Fairly Valued). The stock has 4 warning signs investors should review. Among 441 Business Services companies, EnBio Holdings ranks worse than 93.65% on this metric.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for EnBio Holdings's PEG Ratio or its related term are showing as below:
TSE:6092'
s PEG Ratio Range Over the Past 10 Years
Min: 0.16 Med: 0.58 Max: 14
Current: 12.54
During the past 13 years, EnBio Holdings's highest PEG Ratio was 14.00. The lowest was 0.16. And the median was 0.58.
TSE:6092's PEG Ratio is ranked worse than 93.65% of 441
companies
in the Business Services industry
Industry Median: 1.17
vs TSE:6092: 12.54
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
EnBio Holdings (TSE:6092) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
EnBio Holdings PEG Ratio Related Terms
EnBio Holdings PEG Ratio Historical Data
* Premium members only.
The historical data trend for EnBio Holdings's PEG Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Specialty Business Services subindustry, EnBio Holdings's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
EnBio Holdings PEG Ratio vs Business Services Industry
For the Business Services industry and Industrials sector, EnBio Holdings's PEG Ratio distribution charts can be found below:
* The bar in red indicates where EnBio Holdings's PEG Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
EnBio Holdings (TSE:6092) has a PEG Ratio of 12.55 as of Jul. 17, 2026. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on EnBio Holdings and its competitors. This is 2064% above median its historical median of 0.58. Over the past decade, EnBio Holdings' PEG Ratio has ranged from 0.16 to 14.00. According to the industry distribution chart, EnBio Holdings ranks #413 out of 441 companies in the Business Services industry, placing it in the top 93.7%.
Is EnBio Holdings' PEG Ratio too high?
EnBio Holdings' current PEG Ratio of 12.55 is 2064% above median its 10-year median of 0.58. Over the past 10 years, this metric has ranged from a low of 0.16 to a high of 14.00. The Business Services industry median PEG Ratio is 1.17. EnBio Holdings' value of 12.55 is 972.6% above this industry median. Based on the distribution chart, EnBio Holdings ranks #413 out of 441 companies in the Business Services industry, which is in the bottom quartile relative to peers. Overall, EnBio Holdings has a GF Score™ of 58/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does EnBio Holdings' PEG Ratio compare to CTAS and CPRT?
According to the Business Services industry distribution chart, EnBio Holdings ranks #413 out of 441 companies for PEG Ratio. This places EnBio Holdings in the lower half of its industry. The industry median PEG Ratio is 1.17. EnBio Holdings' value of 12.55 is 972.6% above this benchmark. Historically, EnBio Holdings' own PEG Ratio has ranged from 0.16 to 14.00 over the past decade. While the company's 10-year median is 0.58 vs. the industry median of 1.17, EnBio Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PEG Ratio for a Business Services company?
The median PEG Ratio among Business Services companies is 1.17, based on 441 companies in the industry. Companies in the top quartile (top 25%) have a PEG Ratio significantly above this median, while those in the bottom quartile fall well below. However, PEG Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. EnBio Holdings's current PEG Ratio of 12.55 is 972.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PEG Ratio mean?
A high PEG Ratio can signal that a stock is expensive relative to its fundamentals. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on EnBio Holdings and its competitors. For the Business Services industry, the median PEG Ratio is 1.17 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. EnBio Holdings's current PEG Ratio is 12.55, which is 2064% above median its own 10-year median of 0.58. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EnBio Holdings stock overvalued right now?
Based on GuruFocus' analysis, EnBio Holdings (TSE:6092) is currently considered Fairly Valued. The stock's GF Value™ is 円799.37, compared to a current price of 円728.00 — trading 8.9% below its estimated fair value. The current PEG Ratio is 12.55, which is 2064% above median its 10-year median of 0.58 and 972.6% above the Business Services industry median of 1.17. EnBio Holdings' overall GF Score™ is 58/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PEG Ratio calculated?
PEG Ratio is calculated from a company's financial statements. For EnBio Holdings (TSE:6092), the current PEG Ratio is 12.55 as of Jul. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is EnBio Holdings (TSE:6092) Overvalued in 2026?
Based on GuruFocus' analysis, EnBio Holdings stock appears to be undervalued.
The current stock price of 円728.00 is trading 8.9% below its estimated GF Value™ of 円799.37.
GuruFocus considers EnBio Holdings to be Fairly Valued.
Key valuation signals for TSE:6092:
PEG Ratio: 12.55 (2064% above median its 10-year median of 0.58)
GF Value™: 円799.37 vs. price of 円728.00 (8.9% below fair value)
Industry Position: 972.6% above the Business Services median (#413 of 441)
No single metric tells the full story. See the TSE:6092 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
EnBio Holdings Inc is a Japanese company engaged in environmental solution business, tools and chemicals business, and brownfield revitalization business. The environmental business involves investigation, remediation and risk management consulting of contaminated soil and groundwater; Tools and chemicals business involves sales of chemicals used for environmental work such as site investigation and remediation; and brownfield revitalization business which involves purchasing and regeneration of brownfields. The objective of the company is solving soil and groundwater contamination issues.
58GF Score
Get the complete analysis for TSE:6092
PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:6092 has been successfully added to your 
